{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T20:37:19Z","timestamp":1794429439601,"version":"4.9.1"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T00:00:00Z","timestamp":1274400000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1750-1172-5-11","type":"journal-article","created":{"date-parts":[[2010,5,21]],"date-time":"2010-05-21T14:26:05Z","timestamp":1274451965000},"source":"Crossref","is-referenced-by-count":1009,"title":["Beta-thalassemia"],"prefix":"10.1186","volume":"5","author":[{"given":"Renzo","family":"Galanello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Origa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,21]]},"reference":[{"key":"174_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0950-3536(98)80069-3","volume":"11","author":"J Flint","year":"1998","unstructured":"Flint J, Harding RM, Boyce AJ, Clegg JB: The population genetics of the hemoglobinopathies. Bailliere's Clinical Hematology. 1998, 11: 1-50. 10.1016\/S0950-3536(98)80069-3.","journal-title":"Bailliere's Clinical Hematology"},{"key":"174_CR2","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1196\/annals.1345.003","volume":"1054","author":"EP Vichinsky","year":"2005","unstructured":"Vichinsky EP: Changing patterns of thalassemia worldwide. Ann N Y Acad Sci. 2005, 1054: 18-24. 10.1196\/annals.1345.003.","journal-title":"Ann N Y Acad Sci"},{"key":"174_CR3","volume-title":"Guidelines for the clinical management of thalassemia","author":"Thalassemia International Federation","year":"2008","unstructured":"Thalassemia International Federation: Guidelines for the clinical management of thalassemia. 2008, [ http:\/\/www.thalassemia.org.cy ]2","edition":"2"},{"key":"174_CR4","first-page":"1319","volume-title":"Wintrobe's Clinical Hematology","author":"C Borgna-Pignatti","year":"2004","unstructured":"Borgna-Pignatti C, Galanello R: Thalassemias and related disorders: quantitative disorders of hemoglobin synthesis. Wintrobe's Clinical Hematology. 2004, Lippincott Williams & Wilkins. Philadelphia, 42: 1319-1365. 11","edition":"11"},{"key":"174_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1046\/j.1365-2141.2003.04732.x","volume":"124","author":"C Borgna-Pignatti","year":"2004","unstructured":"Borgna-Pignatti C, Vergine G, Lombardo T, Cappellini MD, Cianciulli P, Maggio A, Renda D, Lai ME, Mandas A, Forni G, Piga A, Bisconte MG: Hepatocellular carcinoma in the thalassemia syndromes. Br J Haematol. 2004, 124: 114-117. 10.1046\/j.1365-2141.2003.04732.x.","journal-title":"Br J Haematol"},{"key":"174_CR6","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1196\/annals.1345.006","volume":"1054","author":"C Borgna-Pignatti","year":"2005","unstructured":"Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Origa R, Piga A, Romeo MA, Zhao H, Cnaan A: Survival and complications in thalassemia. Ann N Y Acad Sci. 2005, 1054: 40-47. 10.1196\/annals.1345.006.","journal-title":"Ann N Y Acad Sci"},{"key":"174_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1046\/j.1365-2141.2001.03200.x","volume":"115","author":"R Galanello","year":"2001","unstructured":"Galanello R, Piras S, Barella S, Leoni GB, Cipollina MD, Perseu L, Cao A: Cholelithiasis and Gilbert's syndrome in homozygous beta-thalassemia. Br J Haematol. 2001, 115: 926-928. 10.1046\/j.1365-2141.2001.03200.x.","journal-title":"Br J Haematol"},{"key":"174_CR8","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.blre.2008.04.001","volume":"22","author":"AT Taher","year":"2008","unstructured":"Taher AT, Otrock ZK, Uthman I, Cappellini MD: Thalassemia and hypercoagulability. Blood Rev. 2008, 22: 283-292. 10.1016\/j.blre.2008.04.001.","journal-title":"Blood Rev"},{"key":"174_CR9","first-page":"965","volume":"11","author":"V De Sanctis","year":"1998","unstructured":"De Sanctis V, Tangerini A, Testa MR, Lauriola AL, Gamberini MR, Cavallini AR, Rigolin F: Final height and endocrine function in Thalassemia Intermedia. J Pediatr Endocrinol Metab. 1998, 11: 965-971.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"174_CR10","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.3324\/haematol.13152","volume":"93","author":"AH Nassar","year":"2008","unstructured":"Nassar AH, Naja M, Cesaretti C, Eprassi B, Cappellini MD, Taher A: Pregnancy outcome in patients with beta-thalassemia intermedia at two tertiary care centers, in Beirut and Milan. Haematologica. 2008, 93: 1586-1587. 10.3324\/haematol.13152.","journal-title":"Haematologica"},{"key":"174_CR11","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1378\/chest.127.5.1523","volume":"127","author":"A Aessopos","year":"2005","unstructured":"Aessopos A, Farmakis D, Deftereos S, Tsironi M, Tassiopoulos S, Moyssakis I, Karagiorga M: Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia. Chest. 2005, 127: 1523-1530. 10.1378\/chest.127.5.1523.","journal-title":"Chest"},{"key":"174_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1182\/blood.V99.1.30","volume":"99","author":"A Aessopos","year":"2002","unstructured":"Aessopos A, Farmakis D, Loukopoulos D: Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes. Blood. 2002, 99: 30-35. 10.1182\/blood.V99.1.30.","journal-title":"Blood"},{"key":"174_CR13","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1365-2141.1992.tb08132.x","volume":"80","author":"SL Thein","year":"1992","unstructured":"Thein SL: Dominant beta thalassaemia: molecular basis and pathophysiology. Br J Haematol. 1992, 80: 273-277. 10.1111\/j.1365-2141.1992.tb08132.x.","journal-title":"Br J Haematol"},{"key":"174_CR14","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1093\/hmg\/10.24.2797","volume":"10","author":"V Viprakasit","year":"2001","unstructured":"Viprakasit V, Gibbons RJ, Broughton BC, Tolmie JL, Brown D, Lunt P, Winter RM, Marinoni S, Stefanini M, Brueton L, Lehmann AR, Higgs DR: Mutations in the general transcription factor TFIIH result in beta- thalassemia in individuals with trichothiodystrophy. Hum Mol Genet. 2001, 10: 2797-2802. 10.1093\/hmg\/10.24.2797.","journal-title":"Hum Mol Genet"},{"key":"174_CR15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1093\/hmg\/11.2.147","volume":"11","author":"K Freson","year":"2002","unstructured":"Freson K, Matthijs G, Thys C, Marien P, Hoylaerts MF, Vermylen J, Van Geet C: Different substitutions at residue D218 of the X-linked transcription factor GATA1 lead to altered clinical severity of macrothrombocytopenia and anemia and are associated with variable skewed X inactivation. Hum Mol Genet. 2002, 11: 147-152. 10.1093\/hmg\/11.2.147.","journal-title":"Hum Mol Genet"},{"key":"174_CR16","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/humu.9479","volume":"28","author":"B Giardine","year":"2007","unstructured":"Giardine B, van Baal S, Kaimakis P, Riemer C, Miller W, Samara M, Kollia P, Anagnou NP, Chui DH, Wajcman H, Hardison RC, Patrinos GP: HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat. 2007, 28: 206-10.1002\/humu.9479.","journal-title":"Hum Mutat"},{"key":"174_CR17","volume-title":"The Sickle Cell Anemia Foundation, Augusta, GA","author":"THJ Huisman","year":"1997","unstructured":"Huisman THJ, Carver MFH, Baysal E: A Syllabus of Thalassemia Mutations. The Sickle Cell Anemia Foundation, Augusta, GA. 1997"},{"key":"174_CR18","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/j.1749-6632.1998.tb10489.x","volume":"850","author":"R Galanello","year":"1998","unstructured":"Galanello R, Cao A: Relationship between genotype and phenotype. Thalassemia intermedia. Ann N Y Acad Sci. 1998, 850: 325-333. 10.1111\/j.1749-6632.1998.tb10489.x.","journal-title":"Ann N Y Acad Sci"},{"key":"174_CR19","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1073\/pnas.0711566105","volume":"105","author":"M Uda","year":"2008","unstructured":"Uda M, Galanello R, Sanna S, Lettre G, Sankaran VG, Chen W, Usala G, Busonero F, Maschio A, Albai G, Piras MG, Sestu N, Lai S, Dei M, Mulas A, Crisponi L, Naitza S, Asunis I, Deiana M, Nagaraja R, Perseu L, Satta S, Cipollina MD, Sollaino C, Moi P, Hirschhorn JN, Orkin SH, Abecasis GR, Schlessinger D, Cao A: Genome-wide association study shows BCL11A associated with peristent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc Natl Acad Sci USA. 2008, 105: 1620-1625. 10.1073\/pnas.0711566105.","journal-title":"Proc Natl Acad Sci USA"},{"key":"174_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1046\/j.1365-2141.1997.3703182.x","volume":"99","author":"R Galanello","year":"1997","unstructured":"Galanello R, Perseu L, Melis MA, Cipollina L, Barella S, Giagu N, Turco MP, Maccioni O, Cao A: Hyperbilirubinaemia in heterozygous b-thalassemia is related to co-inherited Gilbert's syndrome. Br J Haematol. 1997, 99: 433-436. 10.1046\/j.1365-2141.1997.3703182.x.","journal-title":"Br J Haematol"},{"key":"174_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1600-0609.2008.01162.x","volume":"82","author":"R Origa","year":"2009","unstructured":"Origa R, Galanello R, Perseu L, Tavazzi D, Domenica Cappellini M, Terenzani L, Forni GL, Quarta G, Boetti T, Piga A: Cholelithiasis in thalassemia major. Eur J Haematol. 2009, 82: 22-25. 10.1111\/j.1600-0609.2008.01162.x.","journal-title":"Eur J Haematol"},{"key":"174_CR22","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1182\/blood.V92.9.3455","volume":"92","author":"E Economou-Petersen","year":"1998","unstructured":"Economou-Petersen E, Aessopos A, Kladi A, Flevari P, Karabatsos F, Fragodimitri C, Nicolaidis P, Vrettou H, Vassilopoulos D, Karagiorga-Lagana M, Kremastinos DT, Petersen MB: Apolipoprotein E epsilon4 allele as a genetic risk factor for left ventricular failure in homozygous beta-thalassemia. Blood. 1998, 92: 3455-3459.","journal-title":"Blood"},{"key":"174_CR23","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1161\/01.CIR.100.20.2074","volume":"100","author":"DT Kremastinos","year":"1999","unstructured":"Kremastinos DT, Flevari P, Spyropoulou M, Vrettou H, Tsiapras D, Stavropoulos-Giokas CG: Association of heart failure in homozygous beta-thalassemia with the major histocompatibility complex. Circulation. 1999, 100: 2074-2078.","journal-title":"Circulation"},{"key":"174_CR24","first-page":"799","volume":"84","author":"F Longo","year":"1999","unstructured":"Longo F, Zecchina G, Sbaiz L, Fischer R, Piga A, Camaschella C: The influence of hemochromatosis mutations on iron overload of thalassemia major. Haematologica. 1999, 84: 799-803.","journal-title":"Haematologica"},{"key":"174_CR25","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1046\/j.1365-2141.2000.02382.x","volume":"111","author":"S Perrotta","year":"2000","unstructured":"Perrotta S, Cappellini MD, Bertoldo F, Servedio V, Iolascon G, D'Agruma L, Gasparini P, Siciliani MC, Iolascon A: Osteoporosis in \u03b2-thalassemia major patients: analysis of the genetic background. Br J Haematol. 2000, 111: 461-466. 10.1046\/j.1365-2141.2000.02382.x.","journal-title":"Br J Haematol"},{"key":"174_CR26","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1046\/j.1365-2141.2000.02392.x","volume":"111","author":"R Dresner Pollack","year":"2000","unstructured":"Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW: Bone mineral metabolism in adults with \u03b2-thalassemia major and intermedia. Br J Haematol. 2000, 111: 902-907. 10.1046\/j.1365-2141.2000.02392.x.","journal-title":"Br J Haematol"},{"key":"174_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-2141.2008.07175.x","volume":"142","author":"R Origa","year":"2008","unstructured":"Origa R, Satta S, Matta G, Galanello R: Glutathione S-transferase gene polymorphism and cardiac iron overload in thalassemia major. Br J Haematol. 2008, 142: 143-145. 10.1111\/j.1365-2141.2008.07175.x.","journal-title":"Br J Haematol"},{"key":"174_CR28","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.3324\/haematol.2009.005728","volume":"94","author":"MC Sollaino","year":"2009","unstructured":"Sollaino MC, Paglietti ME, Perseu L, Giagu N, Loi D, Galanello R: Association of alpha globin gene quadruplication and heterozygous beta thalassemia in patients with thalassemia intermedia. Haematologica. 2009, 94: 1445-1448. 10.3324\/haematol.2009.005728.","journal-title":"Haematologica"},{"key":"174_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3109\/03630267909069153","volume":"3","author":"R Galanello","year":"1979","unstructured":"Galanello R, Melis MA, Ruggeri R, Addis M, Scalas MT, Maccioni L, Furbetta M, Angius A, Tuveri T, Cao A: Beta0 thalassemia trait in Sardinia. Hemoglobin. 1979, 3: 33-46. 10.3109\/03630267909069153.","journal-title":"Hemoglobin"},{"key":"174_CR30","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1373\/49.5.769","volume":"49","author":"C Vrettou","year":"2003","unstructured":"Vrettou C, Traeger-Synodinos J, Tzetis M, Malamis G, Kanavakis E: Rapid screening of multiple betaglobin gene mutations by real-time PCR on the LightCycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes. Clin Chem. 2003, 49: 769-776. 10.1373\/49.5.769.","journal-title":"Clin Chem"},{"key":"174_CR31","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0950-3536(98)80076-0","volume":"11","author":"A Cao","year":"1998","unstructured":"Cao A, Galanello R, Rosatelli MC: Prenatal diagnosis and screening of the haemoglobinopathies. Baillieres Clin Haematol. 1998, 11: 215-238. 10.1016\/S0950-3536(98)80076-0.","journal-title":"Baillieres Clin Haematol"},{"key":"174_CR32","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/pd.1640","volume":"27","author":"A Mavrou","year":"2007","unstructured":"Mavrou A, Kouvidi E, Antsaklis A, Souka A, Kitsiou Tzeli S, Kolialexi A: Identification of nucleated red blood cells in maternal circulation: a second step in screening for fetal aneuploidies and pregnancy complications. Prenat Diagn. 2007, 27: 150-153. 10.1002\/pd.1640.","journal-title":"Prenat Diagn"},{"key":"174_CR33","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1369\/jhc.4R6362.2005","volume":"53","author":"YM Lo","year":"2005","unstructured":"Lo YM: Recent advances in fetal nucleic acids in maternal plasma. J Histochem Cytochem. 2005, 53: 293-296. 10.1369\/jhc.4R6362.2005.","journal-title":"J Histochem Cytochem"},{"key":"174_CR34","unstructured":"Webthal. [ http:\/\/www.talassemia.it\/sito_eng\/THAL_intro_eng.html ]"},{"key":"174_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1182\/blood-2003-09-3167","volume":"104","author":"MJ Cunningham","year":"2004","unstructured":"Cunningham MJ, Macklin EA, Neufeld EJ, Cohen AR: Thalassemia Clinical Research Network. Complications of beta-thalassemia major in North America. Blood. 2004, 104: 34-39. 10.1182\/blood-2003-09-3167.","journal-title":"Blood"},{"key":"174_CR36","first-page":"1187","volume":"89","author":"C Borgna-Pignatti","year":"2004","unstructured":"Borgna-Pignatti C, Rugolotto S, De Stefano P, Zhao H, Cappellini MD, Del Vecchio GC, Romeo MA, Forni GL, Gamberini MR, Ghilardi R, Piga A, Cnaan A: Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica. 2004, 89: 1187-1193.","journal-title":"Haematologica"},{"key":"174_CR37","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/ajh.2830420116","volume":"42","author":"GM Brittenham","year":"1993","unstructured":"Brittenham GM, Cohen AR, McLaren CE, Martin MB, Griffith PM, Nienhuis AW, Young NS, Allen CJ, Farrell DE, Harris JW: Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol. 1993, 42: 81-85. 10.1002\/ajh.2830420116.","journal-title":"Am J Hematol"},{"key":"174_CR38","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1056\/NEJM200008033430503","volume":"343","author":"E Angelucci","year":"2000","unstructured":"Angelucci E, Brittenham GM, McLaren CE, Ripalti M, Baronciani D, Giardini C, Galimberti M, Polchi P, Lucarelli G: Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000, 343: 327-331. 10.1056\/NEJM200008033430503.","journal-title":"N Engl J Med"},{"key":"174_CR39","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S0168-8278(96)80070-5","volume":"25","author":"JP Villeneuve","year":"1996","unstructured":"Villeneuve JP, Bilodeau M, Lepage R, Cote J, Lefebvre M: Variability in hepatic iron concentration measurement from needle- biopsy specimens. Journal of Hepatology. 1996, 25: 172-177. 10.1016\/S0168-8278(96)80070-5.","journal-title":"Journal of Hepatology"},{"key":"174_CR40","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","volume":"22","author":"LJ Anderson","year":"2001","unstructured":"Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM, Pennell DJ: Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001, 22: 2171-2179. 10.1053\/euhj.2001.2822.","journal-title":"Eur Heart J"},{"key":"174_CR41","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1182\/blood-2003-06-1919","volume":"103","author":"JC Wood","year":"2004","unstructured":"Wood JC, Tyszka JM, Carson S, Nelson MD, Coates TD: Myocardial iron loading in transfusiondependent thalassemia and sickle cell disease. Blood. 2004, 103: 1934-1936. 10.1182\/blood-2003-06-1919.","journal-title":"Blood"},{"key":"174_CR42","first-page":"1388","volume":"91","author":"MA Tanner","year":"2006","unstructured":"Tanner MA, He T, Westwood MA, Firmin DN, Pennell DJ: Thalassemia International Federation Heart T2* Investigators. Multi-center validation of the transferability of the magnetic resonance T2* technique for the quantification of tissue iron. Haematologica. 2006, 91: 1388-","journal-title":"Haematologica"},{"key":"174_CR43","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1182\/blood-2004-01-0177","volume":"105","author":"TG St Pierre","year":"2005","unstructured":"St Pierre TG, Clark PR, Chua-anusorn W, Fleming AJ, Jeffrey GP, Olynyk JK, Pootrakul P, Robins E, Lindeman R: Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 2005, 105: 855-861. 10.1182\/blood-2004-01-0177.","journal-title":"Blood"},{"key":"174_CR44","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05202.x","volume":"127","author":"LJ Anderson","year":"2004","unstructured":"Anderson LJ, Westwood MA, Holden S, Davis B, Prescott E, Wonke B, Porter JB, Walker JM, Pennell DJ: Myocardial iron clearance during reversal of siderotic cardiomyopathy with intravenous desferrioxamine: a prospective study using T2* cardiovascular magnetic resonance. Br J Haematol. 2004, 127: 348-355. 10.1111\/j.1365-2141.2004.05202.x.","journal-title":"Br J Haematol"},{"key":"174_CR45","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1532-429X-10-12","volume":"10","author":"MA Tanner","year":"2008","unstructured":"Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Pibiri M, Nair SV, Walker JM, Pennell DJ: Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J Cardiovasc Magn Reson. 2008, 10: 12-10.1186\/1532-429X-10-12.","journal-title":"J Cardiovasc Magn Reson"},{"key":"174_CR46","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1046\/j.1365-2141.2003.04297.x","volume":"121","author":"R Fischer","year":"2003","unstructured":"Fischer R, Longo F, Nielsen P, Engelhardt R, Hider RC, Piga A: Monitoring long-term efficacy of iron chelation therapy by deferiprone and desferrioxamine in patients with beta-thalassemia major: application of SQUID biomagnetic liver susceptometry. Br J Haematol. 2003, 121: 938-948. 10.1046\/j.1365-2141.2003.04297.x.","journal-title":"Br J Haematol"},{"key":"174_CR47","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000203853","volume":"95","author":"V Gabutti","year":"1996","unstructured":"Gabutti V, Piga A: Results of long-term iron-chelating therapy. Acta Haematol. 1996, 95: 26-36. 10.1159\/000203853.","journal-title":"Acta Haematol"},{"key":"174_CR48","first-page":"795","volume":"3","author":"R Galanello","year":"2003","unstructured":"Galanello R: Deferiprone in the treatment of transfusion-dependent thalassemia: a review and perspective. Ther Clin Risk Manag. 2003, 3: 795-805.","journal-title":"Ther Clin Risk Manag"},{"key":"174_CR49","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","volume":"360","author":"LJ Anderson","year":"2002","unstructured":"Anderson LJ, Wonke B, Prescott E, Holden S, Walker JM, Pennell DJ: Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia. Lancet. 2002, 360: 516-520. 10.1016\/S0140-6736(02)09740-4.","journal-title":"Lancet"},{"key":"174_CR50","first-page":"489","volume":"88","author":"A Piga","year":"2003","unstructured":"Piga A, Gaglioti C, Fogliacco E, Tricta F: Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassemia major: a retrospective analysis. Haematologica. 2003, 88: 489-496.","journal-title":"Haematologica"},{"key":"174_CR51","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","volume":"107","author":"DJ Pennell","year":"2006","unstructured":"Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A, Gotsis ED, Tanner MA, Smith GC, Westwood MA, Wonke B, Galanello R: Randomized controlledtrial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood. 2006, 107: 3738-3744. 10.1182\/blood-2005-07-2948.","journal-title":"Blood"},{"key":"174_CR52","doi-asserted-by":"publisher","first-page":"3733","DOI":"10.1182\/blood-2005-07-2933","volume":"107","author":"C Borgna-Pignatti","year":"2006","unstructured":"Borgna-Pignatti C, Cappellini MD, De Stefano P, Del Vecchio GC, Forni GL, Gamberini MR, Ghilardi R, Piga A, Romeo MA, Zhao H, Cnaan A: Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major. Blood. 2006, 107: 3733-3737. 10.1182\/blood-2005-07-2933.","journal-title":"Blood"},{"key":"174_CR53","first-page":"1420","volume":"91","author":"A Ceci","year":"2006","unstructured":"Ceci A, Baiardi P, Catapano M, Felisi M, Cianciulli P, De Sanctis V, DelVecchio GC, Magnano C, Meo A, Maggio A: Risk factors for death in patients with beta-thalassemia major: results of a case-control study. Haematologica. 2006, 91: 1420-1421.","journal-title":"Haematologica"},{"key":"174_CR54","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1046\/j.1365-2141.1998.01002.x","volume":"103","author":"B Wonke","year":"1998","unstructured":"Wonke B, Wright C, Hoffbrand AV: Combined therapy with deferiprone and desferrioxamine. Br J Haematol. 1998, 103: 361-364. 10.1046\/j.1365-2141.1998.01002.x.","journal-title":"Br J Haematol"},{"key":"174_CR55","first-page":"493","volume":"55","author":"K Balveer","year":"2001","unstructured":"Balveer K, Pryor K, Wonke B: Combined oral and parenteral iron chelation in beta thalassemia major. Med J Malaysia. 2001, 55: 493-497.","journal-title":"Med J Malaysia"},{"key":"174_CR56","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/sj.thj.6200550","volume":"5","author":"V Alymara","year":"2004","unstructured":"Alymara V, Bourantas D, Chaidos A, Bouranta P, Gouva M, Vassou A, Tzouvara E, Bourantas KL: Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiprone. Hematol J. 2004, 5: 475-479. 10.1038\/sj.thj.6200550.","journal-title":"Hematol J"},{"issue":"Suppl 1","key":"174_CR57","first-page":"79","volume":"3","author":"K Farmaki","year":"2002","unstructured":"Farmaki K, Anagnostopoulos G, Platis O, Gotsis E, Toulas P: Combined chelation therapy in patients with thalassemia major: a fast and effective method of reducing ferritin levels and cardiological complications [abstract]. Hematol J. 2002, 3 (Suppl 1): 79-","journal-title":"Hematol J"},{"key":"174_CR58","doi-asserted-by":"publisher","first-page":"120a","DOI":"10.1182\/blood.V100.1.120","volume":"100","author":"A Kattamis","year":"2002","unstructured":"Kattamis A, Kassou C, Ladis V, Berdoussi H, Papasotiriou I, Kattamis C: Safety and efficacy of combining deferiprone and deferoxamine in iron chelation therapy in patients with thalassemia [abstract]. Blood. 2002, 100: 120a-10.1182\/blood.V100.1.120.","journal-title":"Blood"},{"key":"174_CR59","first-page":"1309","volume":"90","author":"R Origa","year":"2005","unstructured":"Origa R, Bina P, Agus A, Crobu G, Defraia E, Dessi C, Leoni GB, Muroni PP, Galanello R: Combined therapy with deferiprone and desferrioxamine in thalassemia major. Haematologica. 2005, 90: 1309-1314.","journal-title":"Haematologica"},{"key":"174_CR60","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00277-003-0820-0","volume":"83","author":"KH Wu","year":"2004","unstructured":"Wu KH, Chang JS, Tsai CH, Peng CT: Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients withbeta-thalassemia major. Ann Hematol. 2004, 83: 471-473. 10.1007\/s00277-003-0820-0.","journal-title":"Ann Hematol"},{"key":"174_CR61","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1600-0609.2004.00335.x","volume":"74","author":"M Tsironi","year":"2005","unstructured":"Tsironi M, Deftereos S, Andriopoulos P, Farmakis D, Meletis J, Aessopos A: Reversal of heart failure in thalassemia major by combined chelation therapy: a case report. Eur J Haematol. 2005, 74: 84-85. 10.1111\/j.1600-0609.2004.00335.x.","journal-title":"Eur J Haematol"},{"key":"174_CR62","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ejheart.2006.08.006","volume":"9","author":"M Porcu","year":"2007","unstructured":"Porcu M, Landis N, Salis S, Corda M, Orru P, Serra E, Usai B, Matta G, Galanello R: Effects of combined deferiprone and desferrioxamine iron chelating therapy in beta-thalassemia major end-stage heart failure: a case report. Eur J Heart Fail. 2007, 9: 320-322. 10.1016\/j.ejheart.2006.08.006.","journal-title":"Eur J Heart Fail"},{"key":"174_CR63","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","volume":"115","author":"MA Tanner","year":"2007","unstructured":"Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A, Roughton M, Assomull R, Nair SV, Walker JM, Pennell DJ: A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation. 2007, 115: 1876-1884. 10.1161\/CIRCULATIONAHA.106.648790.","journal-title":"Circulation"},{"key":"174_CR64","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.1182\/blood-2005-08-3430","volume":"107","author":"MD Cappellini","year":"2006","unstructured":"Cappellini MD, Cohen A, Piga A, Bejaoui M, Perrotta S, Agaoglu L, Aydinok Y, Kattamis A, Kilinc Y, Porter J, Capra M, Galanello R, Fattoum S, Drelichman G, Magnano C, Verissimo M, Athanassiou-Metaxa M, Giardina P, Kourakli-Symeonidis A, Janka-Schaub G, Coates T, Vermylen C, Olivieri N, Thuret I, Opitz H, Ressayre-Djaffer C, Marks P, Alberti D: A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia. Blood. 2006, 107: 3455-3462. 10.1182\/blood-2005-08-3430.","journal-title":"Blood"},{"key":"174_CR65","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1586\/17512433.1.2.231","volume":"1","author":"R Galanello","year":"2008","unstructured":"Galanello R, Origa R: Once-daily oral deferasirox for the treatment of transfusional iron overload. Ex Rev of Clin Pharma. 2008, 1: 231-240. 10.1586\/17512433.1.2.231.","journal-title":"Ex Rev of Clin Pharma"},{"key":"174_CR66","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1517\/14656566.9.13.2391","volume":"9","author":"MD Cappellini","year":"2008","unstructured":"Cappellini MD, Taher A: Long-term experience with deferasirox (ICL670), a once-daily oral iron chelator, in the treatment of transfusional iron overload. Expert Opin Pharmacother. 2008, 9: 2391-2402. 10.1517\/14656566.9.13.2391.","journal-title":"Expert Opin Pharmacother"},{"key":"174_CR67","volume-title":"Novartis Pharma AG.","author":"Exjade (deferasirox) Summary of product characteristics.","year":"2006","unstructured":"Exjade (deferasirox) Summary of product characteristics. Novartis Pharma AG. 2006, [ http:\/\/www.ema.europa.eu\/humandocs\/PDFs\/EPAR\/exjade\/H-670-en8.pdf ]"},{"key":"174_CR68","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3324\/haematol.12413","volume":"93","author":"E Angelucci","year":"2008","unstructured":"Angelucci E, Barosi G, Camaschella C, Cappellini MD, Cazzola M, Galanello R, Marchetti M, Piga A, Tura S: Italian Society of Hematology practice guidelines for the management of iron overload in thalassemia major and related disorders. Haematologica. 2008, 93: 741-752. 10.3324\/haematol.12413.","journal-title":"Haematologica"},{"key":"174_CR69","unstructured":"U.K. Thalassemia Society: Standards for the Clinical Care of Children and Adults with Thalassaemia in the UK - Revised 2008 edition. [ http:\/\/www.ukts.org\/pdfs\/awareness\/ukts-standards-2008.pdf ]"},{"key":"174_CR70","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1515\/JPEM.2004.17.1.17","volume":"17","author":"I Karydis","year":"2004","unstructured":"Karydis I, Karagiorga-Lagana M, Nounopoulos C, Tolis G: Basal and stimulated levels of growth hormone, insulin-like growth factor-I (IGF-I), IGF-I binding and IGF-binding proteins in betathalassemia major. J Pediatr Endocrinol Metab. 2004, 17: 17-25.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"174_CR71","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s00277-003-0712-3","volume":"82","author":"KH Wu","year":"2003","unstructured":"Wu KH, Tsai FJ, Peng CT: Growth hormone (GH) deficiency in patients with beta thalassemia major and the efficacy of recombinant GH treatment. Ann Hematol. 2003, 82: 637-640. 10.1007\/s00277-003-0712-3.","journal-title":"Ann Hematol"},{"key":"174_CR72","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1159\/000064766","volume":"58","author":"V De Sanctis","year":"2002","unstructured":"De Sanctis V: Growth and puberty and its management in thalassemia. Horm Res. 2002, 58: 72-79. 10.1159\/000064766.","journal-title":"Horm Res"},{"key":"174_CR73","first-page":"891","volume":"11","author":"V De Sanctis","year":"1998","unstructured":"De Sanctis V, Vullo C, Urso L, Rigolin F, Cavallini A, Caramelli K, Daugherty C, Mazer N: Clinical experience using the Androderm testosterone transdermal system in hypogonadal adolescents and young men with beta-thalassemia major. J Pediatr Endocrinol Metab. 1998, 11: 891-900.","journal-title":"J Pediatr Endocrinol Metab"},{"key":"174_CR74","first-page":"296","volume":"2","author":"N Skordis","year":"2004","unstructured":"Skordis N, Petrikkos L, Toumba M, Hadjigavriel M, Sitarou M, Kolnakou A, Skordos G, Pangalou E, Christou S: Update on fertility in thalassemia major. Pediatr Endocrinol Rev. 2004, 2: 296-302.","journal-title":"Pediatr Endocrinol Rev"},{"key":"174_CR75","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3324\/haematol.2009.012393","volume":"95","author":"R Origa","year":"2010","unstructured":"Origa R, Piga A, Quarta G, Forni G, Longo F, Melpignano A, Galanello R: Pregnancy and betathalassemia: an Italian multicentric experience. Haematologica. 2010, 95: 376-81. 10.3324\/haematol.2009.012393.","journal-title":"Haematologica"},{"key":"174_CR76","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1111\/j.1365-2141.2009.07970.x","volume":"148","author":"K Farmaki","year":"2010","unstructured":"Farmaki K, Tzoumari I, Pappa C, Chouliaras G, Berdoukas V: Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major. Br J Haematol. 2010, 148: 466-475. 10.1111\/j.1365-2141.2009.07970.x.","journal-title":"Br J Haematol"},{"key":"174_CR77","first-page":"285","volume":"2","author":"A Mangiagli","year":"2004","unstructured":"Mangiagli A, Campisi S, De Sanctis V, Nicoletti MC, Cardinale G, Galati MC, Raiola G, Rigano P, Saviano A, Study Group of the Italian Pediatric and Diabetes Society (SIEDP) on Endocrine Complications in Non-Endocrine Disease: Effects of acarbose in patients with beta-thalassemia major and abnormal glucose homeostasis. Pediatr Endocrinol Rev. 2004, 2: 285-291.","journal-title":"Pediatr Endocrinol Rev"},{"key":"174_CR78","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1365-2141.2006.06203.x","volume":"134","author":"K Farmaki","year":"2006","unstructured":"Farmaki K, Angelopoulos N, Anagnostopoulos G, Gotsis E, Rombopoulos G, Tolis G: Effect of enhanced iron chelation therapy on glucose metabolism in patients with beta-thalassaemia major. Br J Haematol. 2006, 134: 438-444. 10.1111\/j.1365-2141.2006.06203.x.","journal-title":"Br J Haematol"},{"key":"174_CR79","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/BF03345587","volume":"31","author":"A Gaudio","year":"2008","unstructured":"Gaudio A, Morabito N, Xourafa A, Macri I, Meo A, Morgante S, Trifiletti A, Lasco A, Frisina N: Bisphosphonates in the treatment of thalassemia-associated osteoporosis. J Endocrinol Invest. 2008, 31: 181-184.","journal-title":"J Endocrinol Invest"},{"key":"174_CR80","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/00008480-200302000-00005","volume":"15","author":"J Gaziev","year":"2003","unstructured":"Gaziev J, Lucarelli G: Stem cell transplantation for hemoglobinopathies. Curr Opin Pediatr. 2003, 15: 24-31. 10.1097\/00008480-200302000-00005.","journal-title":"Curr Opin Pediatr"},{"key":"174_CR81","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1196\/annals.1345.023","volume":"1054","author":"G La Nasa","year":"2005","unstructured":"La Nasa G, Argiolu F, Giardini C, Pession A, Fagioli F, Caocci G, Vacca A, De Stefano P, Piras E, Ledda A, Piroddi A, Littera R, Nesci S, Locatelli F: Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group. Ann N Y Acad Sci. 2005, 1054: 186-195. 10.1196\/annals.1345.023.","journal-title":"Ann N Y Acad Sci"},{"key":"174_CR82","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1182\/blood-2002-07-2090","volume":"101","author":"F Locatelli","year":"2003","unstructured":"Locatelli F, Rocha V, Reed W, Bernaudin F, Ertem M, Grafakos S, Brichard B, Li X, Nagler A, Giorgiani G, Haut PR, Brochstein JA, Nugent DJ, Blatt J, Woodard P, Kurtzberg J, Rubin CM, Miniero R, Lutz P, Raja T, Roberts I, Will AM, Yaniv I, Vermylen C, Tannoia N, Garnier F, Ionescu I, Walters MC, Lubin BH, Gluckman E: Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. Blood. 2003, 101: 2137-2143. 10.1182\/blood-2002-07-2090.","journal-title":"Blood"},{"key":"174_CR83","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1365-2141.2008.07016.x","volume":"141","author":"FO Pinto","year":"2008","unstructured":"Pinto FO, Roberts I: Cord blood stem cell transplantation for haemoglobinopathies. Br J Haematol. 2008, 141: 309-324.","journal-title":"Br J Haematol"},{"key":"174_CR84","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0140-6736(03)13806-8","volume":"362","author":"MG Orofino","year":"2003","unstructured":"Orofino MG, Argiolu F, Sanna MA, Rosatelli MC, Tuveri T, Scalas MT, Badiali M, Cossu P, Puddu R, Lai ME, Cao A: Fetal HLA typing in beta thalassemia: implications for haemopoietic stem-cell transplantation. Lancet. 2003, 362: 41-42. 10.1016\/S0140-6736(03)13806-8.","journal-title":"Lancet"},{"key":"174_CR85","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2141.2007.06654.x","volume":"138","author":"C Borgna-Pignatti","year":"2007","unstructured":"Borgna-Pignatti C: Modern treatment of thalassaemia intermedia. Br J Haematol. 2007, 138: 291-304. 10.1111\/j.1365-2141.2007.06654.x.","journal-title":"Br J Haematol"},{"key":"174_CR86","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3324\/haematol.10842","volume":"92","author":"R Origa","year":"2007","unstructured":"Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E: Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica. 2007, 92: 583-588. 10.3324\/haematol.10842.","journal-title":"Haematologica"},{"key":"174_CR87","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1002\/dvdy.20802","volume":"235","author":"BS Pace","year":"2006","unstructured":"Pace BS, Zein S: Understanding mechanisms of gamma-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction. Dev Dyn. 2006, 235: 1727-1737. 10.1002\/dvdy.20802.","journal-title":"Dev Dyn"},{"key":"174_CR88","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1182\/blood-2003-01-0117","volume":"102","author":"M Bradai","year":"2003","unstructured":"Bradai M, Abad MT, Pissard S, Lamraoui F, Skopinski L, de Montalembert M: Hydroxycarbamide can eliminate transfusion requirements in children with severe beta-thalassemia. Blood. 2003, 102: 1529-1530. 10.1182\/blood-2003-01-0117.","journal-title":"Blood"},{"key":"174_CR89","first-page":"1172","volume":"89","author":"M Yavarian","year":"2004","unstructured":"Yavarian M, Karimi M, Bakker E, Harteveld CL, Giordano PC: Response to hydroxycarbamidetreatment in Iranian transfusion-dependent beta-thalassemia patients. Haematologica. 2004, 89: 1172-1178.","journal-title":"Haematologica"},{"key":"174_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/hum.2006.151","volume":"18","author":"M Sadelain","year":"2007","unstructured":"Sadelain M, Boulad F, Galanello R, Giardina P, Locatelli F, Maggio A, Rivella S, Riviere I, Tisdale J: Therapeutic options for patients with severe \u03b2-thalassemia: the need for globin gene therapy. Hum Gene Ther. 2007, 18: 1-9. 10.1089\/hum.2006.151.","journal-title":"Hum Gene Ther"},{"key":"174_CR91","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1182\/blood-2004-04-1427","volume":"104","author":"G Puthenveetil","year":"2004","unstructured":"Puthenveetil G, Scholes J, Carbonell D, Qureshi N, Xia P, Zeng L, Li S, Yu Y, Hiti AL, Yee JK, Malik P: Successful correction of the human beta-thalassemia major phenotype using a lentiviral vector. Blood. 2004, 104: 3445-3453. 10.1182\/blood-2004-04-1427.","journal-title":"Blood"},{"key":"174_CR92","first-page":"1106","volume":"88","author":"C Borgna-Pignatti","year":"2003","unstructured":"Borgna-Pignatti C, Rigon F, Merlo L, Chakrok R, Micciolo R, Perseu L, Galanello R: Thalassemia minor, the Gilbert mutation, and the risk of gallstones. Haematologica. 2003, 88: 1106-1109.","journal-title":"Haematologica"},{"key":"174_CR93","first-page":"1187","volume":"91","author":"P Telfer","year":"2006","unstructured":"Telfer P, Coen PG, Christou S, Hadjigavriel M, Kolnakou A, Pangalou E, Pavlides N, Psiloines M, Simamonian K, Skordos G, Sitarou M, Angastiniotis M: Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004. Haematologica. 2006, 91: 1187-1192.","journal-title":"Haematologica"},{"key":"174_CR94","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1532-429X-10-42","volume":"10","author":"B Modell","year":"2008","unstructured":"Modell B, Khan M, Darlison M, Westwood MA, Ingram D, Pennell DJ: Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008, 10: 42-10.1186\/1532-429X-10-42.","journal-title":"J Cardiovasc Magn Reson"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-5-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1750-1172-5-11\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1750-1172-5-11.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T18:44:22Z","timestamp":1711478662000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/1750-1172-5-11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,21]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["174"],"URL":"https:\/\/doi.org\/10.1186\/1750-1172-5-11","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,21]]},"article-number":"11"}}